336 related articles for article (PubMed ID: 22849613)
1. N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice.
Kim JK; Cho SM; Kang SH; Kim E; Yi H; Yun ES; Lee DG; Cho HJ; Paik YH; Choi YK; Haam SJ; Shin HC; Lee DK
J Gastroenterol Hepatol; 2012 Nov; 27(11):1745-51. PubMed ID: 22849613
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
Jüngst C; Sreejayan N; Zündt B; Müller I; Spelsberg FW; Hüttl TP; Kullak-Ublick GA; del Pozo R; Jüngst D; von Ritter C
Eur J Clin Invest; 2008 Sep; 38(9):634-9. PubMed ID: 18837739
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment with n-3 polyunsaturated fatty acids and ursodeoxycholic acid dissolves cholesterol gallstones in mice.
Jang SI; Fang S; Kim KP; Ko Y; Kim H; Oh J; Hong GY; Lee SY; Kim JM; Noh I; Lee DK
Sci Rep; 2019 Sep; 9(1):12740. PubMed ID: 31484954
[TBL] [Abstract][Full Text] [Related]
4. Effect of eicosapentaenoic acid on cholesterol gallstone formation in C57BL/6J mice.
Cho SM; Park JA; Kim NH; Kim DS; Zhang D; Yi H; Cho HJ; Kim JK; Lee DK; Kim JS; Shin HC
Mol Med Rep; 2015 Jan; 11(1):362-6. PubMed ID: 25333303
[TBL] [Abstract][Full Text] [Related]
5. Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice.
Wang HH; Afdhal NH; Gendler SJ; Wang DQ
Gastroenterology; 2006 Jul; 131(1):210-22. PubMed ID: 16831603
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid decreases viscosity and sedimentable fractions of gallbladder bile in patients with cholesterol gallstones.
Fischer S; Müller I; Zündt BZ; Jüngst C; Meyer G; Jüngst D
Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):305-11. PubMed ID: 15195895
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice.
Kim JK; Lee KS; Lee DK; Lee SY; Chang HY; Choi J; Lee JI
Exp Mol Med; 2014 Dec; 46(12):e127. PubMed ID: 25523099
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
Tsuchida T; Shiraishi M; Ohta T; Sakai K; Ishii S
Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
[TBL] [Abstract][Full Text] [Related]
9. Effects of sphingolipid synthesis inhibition on cholesterol gallstone formation in C57BL/6J mice.
Lee BJ; Kim JS; Kim BK; Jung SJ; Joo MK; Hong SG; Kim JS; Kim JH; Yeon JE; Park JJ; Byun KS; Bak YT; Yoo HS; Oh S
J Gastroenterol Hepatol; 2010 Jun; 25(6):1105-10. PubMed ID: 20594226
[TBL] [Abstract][Full Text] [Related]
10. Ezetimibe prevents cholesterol gallstone formation in mice.
Zúñiga S; Molina H; Azocar L; Amigo L; Nervi F; Pimentel F; Jarufe N; Arrese M; Lammert F; Miquel JF
Liver Int; 2008 Aug; 28(7):935-47. PubMed ID: 18783541
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones.
Amigo L; Castro J; Miquel JF; Zanlungo S; Young S; Nervi F
Gastroenterology; 2006 Dec; 131(6):1870-8. PubMed ID: 17064699
[TBL] [Abstract][Full Text] [Related]
12. The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models.
Fan N; Meng K; Zhang Y; Hu Y; Li D; Gao Q; Wang J; Li Y; Wu S; Cui Y
Lipids Health Dis; 2020 Jul; 19(1):158. PubMed ID: 32615989
[TBL] [Abstract][Full Text] [Related]
13. Lith genes control mucin accumulation, cholesterol crystallization, and gallstone formation in A/J and AKR/J inbred mice.
Lammert F; Wang DQ; Wittenburg H; Bouchard G; Hillebrandt S; Taenzler B; Carey MC; Paigen B
Hepatology; 2002 Nov; 36(5):1145-54. PubMed ID: 12395324
[TBL] [Abstract][Full Text] [Related]
14. Combination of curcumin and piperine prevents formation of gallstones in C57BL6 mice fed on lithogenic diet: whether NPC1L1/SREBP2 participates in this process?
Li Y; Li M; Wu S; Tian Y
Lipids Health Dis; 2015 Sep; 14():100. PubMed ID: 26335572
[TBL] [Abstract][Full Text] [Related]
15. Effect of ursodeoxycholic acid on inflammatory infiltrate in gallbladder muscle of cholesterol gallstone patients.
Carotti S; Guarino MP; Cicala M; Perrone G; Alloni R; Segreto F; Rabitti C; Morini S
Neurogastroenterol Motil; 2010 Aug; 22(8):866-73, e232. PubMed ID: 20426797
[TBL] [Abstract][Full Text] [Related]
16. The effects of ursodeoxycholic acid alone and ursodeoxycholic acid plus low-dose acetylsalicylic acid on radiolucent gallstones.
Tuncer I; Harman M; Mercan R; Oztürk M; Arslan I; Meral C; Türkdoğan MK
Turk J Gastroenterol; 2003 Jun; 14(2):91-6. PubMed ID: 14614633
[TBL] [Abstract][Full Text] [Related]
17. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
Sahlin S
Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
Asai Y; Yamada T; Tsukita S; Takahashi K; Maekawa M; Honma M; Ikeda M; Murakami K; Munakata Y; Shirai Y; Kodama S; Sugisawa T; Chiba Y; Kondo Y; Kaneko K; Uno K; Sawada S; Imai J; Nakamura Y; Yamaguchi H; Tanaka K; Sasano H; Mano N; Ueno Y; Shimosegawa T; Katagiri H
Gastroenterology; 2017 May; 152(6):1521-1535.e8. PubMed ID: 28088462
[TBL] [Abstract][Full Text] [Related]
19. Metformin treatment prevents gallstone formation but mimics porcelain gallbladder in C57Bl/6 mice.
Dorvash MR; Khoshnood MJ; Saber H; Dehghanian A; Mosaddeghi P; Firouzabadi N
Eur J Pharmacol; 2018 Aug; 833():165-172. PubMed ID: 29883669
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
